by Maria Zannes | Apr 9, 2024 | Press Releases
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening SAN ANTONIO, Texas (April 9, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) , a biotechnology company focused on the need for...
by Maria Zannes | Apr 1, 2024 | Press Releases
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results SAN ANTONIO, Texas (April 1, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) , a biotechnology company focused on commercializing noninvasive tests for the detection...
by Maria Zannes | Mar 8, 2024 | Press Releases
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement SAN ANTONIO, Texas (March 5, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) today announced it has closed a securities purchase...
by Maria Zannes | Mar 6, 2024 | Press Releases
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement SAN ANTONIO, Texas (March 5, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) today announced it has entered into a securities...
by Maria Zannes | Mar 5, 2024 | Press Releases
Increasing physician interest, newly approved reimbursement code driving growth SAN ANTONIO, Texas (March 5, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of...
by Maria Zannes | Feb 21, 2024 | Press Releases
SAN ANTONIO, Texas (Feb. 21, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company news. Lung...
